Related Experiment Video
Updated: Mar 6, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
873
Peptic Ulcer Disease in Bangladesh: A Multi-centre Study
1Dr Chanchal Kumar Ghosh, Associate Professor, Department of Gastroenterology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbagh, Dhaka, Bangladesh;
Mymensingh Medical Journal : MMJ
|March 7, 2017
Summary
Peptic ulcer prevalence in Bangladesh has decreased significantly since the 1980s. Endoscopic data from 2012-2013 reveals lower rates of peptic ulcer disease (PUD) and related complications.
Area of Science:
- Gastroenterology
- Epidemiology
Background:
- Global incidence of peptic ulcer disease (PUD) shows a declining trend.
- Previous studies indicated a PUD point prevalence of approximately 15% in Bangladesh during the 1980s.
Purpose of the Study:
- To determine the current prevalence of peptic ulcer disease (PUD) through endoscopic examinations in Bangladesh.
- To identify any shifts in the occurrence trends of PUD within Bangladesh.
Main Methods:
- Retrospective analysis of endoscopic records from tertiary referral centers in Dhaka city.
- Data collected between January 2012 and July 2013.
- Inclusion criteria: patients diagnosed with duodenal ulcer, benign gastric ulcer, pre-pyloric ulcer, or gastric outlet obstruction due to peptic ulcer.
Main Results:
- A total of 5608 subjects were analyzed.
- Duodenal ulcers were diagnosed in 415 patients (7.4%).
- Benign gastric ulcers were found in 184 patients (3.28%).
- Gastric outlet obstruction related to peptic ulcer affected 23 patients (0.40%).
Conclusions:
- The current endoscopic prevalence of peptic ulcer disease (PUD) in Bangladesh is lower than previously reported.
- These findings suggest a continued downward trend in PUD incidence in the region.
More Related Videos
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
728
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
728
01:30Peptic Ulcer Disease I: Introduction
962
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
962
01:26Peptic Ulcer Disease IV: Management
593
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
593
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.4K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.4K
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.4K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.4K
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.7K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.7K